How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

EN

NYSE:ENZ
Get a brief AI stock analysisSaves ~ 15 minutes of your time

EN

Enzo Biochem IncNYSE ENZ Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNYS - New York Stock Exchange, Inc

FAIR VALUE

Is ENZ undervalued compared to its fair value?

The fair value of ENZ stock is hidden USD. Relative to the market price of 1.14 USD Enzo Biochem Inc is hidden.

Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which focuses on delivering and applying advanced technology capabilities to produce affordable reliable products and services tha...[More about valuation]

Enzo Biochem Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.058 $B

Price:

1.14 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.059

FINANCIALS

Enzo Biochem financial for reporting period

Income Statement

0.008 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0014 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.003 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.008 B 100%
0.0037 B 47%
-0.0014 B -17%
-0.003 B -38%

Balance Sheet

0.093 B
0.069 B

0.0039 B

Financial Position Analysis

Assets

0.093 B
Current Assets
0.076 B
Total non-current assets
0.018 B

Total current liabilities
0.022 B
Total non-current liabilities
0.0028 B

Cash Flow Statement

-N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0029 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Enzo Biochem fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

10 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-180 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
7 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is ENZ attractive for investment based on fundamental analysis?

ENZ stock rating is hidden. Enzo Biochem is a hidden by Eyestock methodology.

Get ENZ Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

14

Gross Margin:

41

CFO / Debt ratio:

hidden

Current ratio:

2.964

Debt / Equity ratio:

0.046

ROE:

10

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

ENZ analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for ENZ to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Enzo Biochem Inc competitors

UN

UNH

UnitedHealth Group Inc

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. The company is headquartered in Hopkins, Minnesota and currently...

Discover

EL

ELV

Elevance Health Inc

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, I...

Discover

CI

CI

Cigna Group

The Cigna Group is engaged in the provision of global health services. The company is headquartered in Bloomfield, Connecticut and currently employs 71,300 full-time employees. Th...

Discover

Enzo Biochem Inc dividends

ENZ dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About ENZ stock

About the company Enzo Biochem Inc

Market cap $B

0.058

Dividend yield

Shares outstanding

49.6628 B

Enzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which focuses on delivering and applying advanced technology capabilities to produce affordable reliable products and services that enable customers to meet their clinical needs. The company is headquartered in Farmingdale, New York and currently employs 465 full-time employees. The firm is focused on delivering and applying advanced technology capabilities to produce products and services that enable its customers to meet their clinical needs. The firm operates through three segments. Enzo Clinical Lab segment is a clinical reference laboratory, which provides a range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies. Enzo Life Sciences segment manufactures, develops and markets products and tools for clinical research, drug development and bioscience research customers worldwide. Enzo Life Sciences has developed products used in the identification of genomic information by laboratories around the world. Enzo Therapeutics is a biopharmaceutical venture that has developed multiple approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases.

ENZ profile

  • Ticker

    ENZ

  • Country

    USA

  • Exchange

    XNYS - New York Stock Exchange, Inc

  • Report currency

    USD - US dollar

  • IPO date

    13 June 1980

  • Sector

    Healthсare

  • Industry

    Health Care Providers & Services

  • Employees

    465

  • City

    Farmingdale

  • Address

    60 Executive Blvd

  • Cusip

    294100102